A detailed history of Lakeridge Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lakeridge Wealth Management LLC holds 3,029 shares of ABBV stock, worth $554,549. This represents 0.33% of its overall portfolio holdings.

Number of Shares
3,029
Previous 3,129 3.2%
Holding current value
$554,549
Previous $537 Million 11.47%
% of portfolio
0.33%
Previous 0.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$163.84 - $199.33 $16,384 - $19,933
-100 Reduced 3.2%
3,029 $598 Million
Q2 2024

Aug 01, 2024

SELL
$154.79 - $180.76 $2,631 - $3,072
-17 Reduced 0.54%
3,129 $537 Million
Q1 2024

Apr 29, 2024

SELL
$159.82 - $182.1 $37,397 - $42,611
-234 Reduced 6.92%
3,146 $573 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $465,088 - $523,798
3,380 New
3,380 $524 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lakeridge Wealth Management LLC Portfolio

Follow Lakeridge Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lakeridge Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lakeridge Wealth Management LLC with notifications on news.